CME 8 Session - EANM'15


Cardiovascular & EACVI: Imaging in Heart Failure: Focus on Nuclear Medicine Techniques and Clinical Implications


Educational objectives:

  1. Better understand the clinical perspective and therapeutic options of patients with heart failure
  2. Understand how cardiovascular imaging may help in the identification of heart failure patients that most likely will benefit from the different therapeutic options:

              a.     revascularization

              b.     cardiac resynchronization therapy (CRT)

              c.     implantable cardiac defibrillators (ICD)



Heart failure imposes an enormous and growing healthcare burden in Europe and the United States (U.S.). In the U.S. approximately 5.7 million people (2.4% of the U.S. population) have heart failure, with 670,000 new cases diagnosed yearly. Therapeutic options for heart failure have advanced significantly. Both pharmacotherapy, coronary artery revascularization and implantable devices (e.g., biventricular pacemakers for cardiac resynchronization therapy (CRT) and implantable cardiac defibrillators (ICD)) have been associated with improved mortality and functional status, but have significant accompanying costs and their cost-effectiveness have been challenged.


Improved tools to identify candidates that most likely will benefit from the therapeutic intervention are needed. Cardiovascular imaging may have the potential to identify these patients, thus, potentially improve cost-effectiveness.


A short description by Hein J. Verberne, Vice Chair of the EANM Cardiovascular Committee.

User action required
If you have the permission to view this publication, please log in.


Quick navigation